Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Buckner

Showing results (291-300 of 417) with videos related to

Pageof 42
Sort By:
Annals of Internal Medicine|August 1, 1982
Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantationK M Sullivan, R Storb, H M Shulman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphomaS I Bearman, F R Appelbaum, A Back, et al.
Pediatrics|February 1, 1986
Bone marrow transplantation experience for children with aplastic anemiaJ E Sanders, J Whitehead, R Storb, et al.
Blood|January 1, 1987
Treatment of preleukemic syndromes with marrow transplantationF R Appelbaum, R Storb, R E Ramberg, et al.
Leukemia Research|January 1, 1982
Allogeneic marrow transplantation for acute leukemia in relapseC Badger, C D Buckner, E D Thomas, et al.
Stem Cells (Dayton, Ohio)|January 1, 1996
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factorW I Bensinger, R A Clift, C Anasetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Ovarian function following marrow transplantation for aplastic anemia or leukemiaJ E Sanders, C D Buckner, D Amos, et al.
Bone Marrow Transplantation|June 1, 1990
Gynecological abnormalities following allogeneic bone marrow transplantationM A Schubert, K M Sullivan, M M Schubert, et al.
Bone Marrow Transplantation|January 1, 1995
Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignanciesM H Lynch, F B Petersen, F R Appelbaum, et al.
Annals of Internal Medicine|May 1, 1984
Allogeneic marrow transplantation in the treatment of preleukemiaF R Appelbaum, R Storb, R E Ramberg, et al.
Pageof 42

Showing results (291-300 of 417) with videos related to

Sort By:
Pageof 42
Annals of Internal Medicine|August 1, 1982
Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantationK M Sullivan, R Storb, H M Shulman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphomaS I Bearman, F R Appelbaum, A Back, et al.
Pediatrics|February 1, 1986
Bone marrow transplantation experience for children with aplastic anemiaJ E Sanders, J Whitehead, R Storb, et al.
Blood|January 1, 1987
Treatment of preleukemic syndromes with marrow transplantationF R Appelbaum, R Storb, R E Ramberg, et al.
Leukemia Research|January 1, 1982
Allogeneic marrow transplantation for acute leukemia in relapseC Badger, C D Buckner, E D Thomas, et al.
Stem Cells (Dayton, Ohio)|January 1, 1996
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factorW I Bensinger, R A Clift, C Anasetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Ovarian function following marrow transplantation for aplastic anemia or leukemiaJ E Sanders, C D Buckner, D Amos, et al.
Bone Marrow Transplantation|June 1, 1990
Gynecological abnormalities following allogeneic bone marrow transplantationM A Schubert, K M Sullivan, M M Schubert, et al.
Bone Marrow Transplantation|January 1, 1995
Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignanciesM H Lynch, F B Petersen, F R Appelbaum, et al.
Annals of Internal Medicine|May 1, 1984
Allogeneic marrow transplantation in the treatment of preleukemiaF R Appelbaum, R Storb, R E Ramberg, et al.
Pageof 42